Merck (MRK) Operating Margin (2009 - 2026)

Merck (MRK) has reported Operating Margin for 18 consecutive years, with 3.52% the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Margin fell 3510.0% year-over-year to 3.52% in Q2 2026; TTM through Jun 2026 was 15.19%, a 1481.0% decrease from a year earlier, with the FY2025 full-year figure at 32.64%, up 161.0% from the prior year.
• Operating Margin was 3.52% for Q2 2026 at Merck, up from 20.85% in the prior quarter.
• Over five years, Operating Margin peaked at 46.27% in Q4 2025 and troughed at 34.34% in Q2 2023.
• A 5-year average of 23.11% and a median of 29.54% in 2024 frame the typical range for Operating Margin.
• Across the five-year window, Operating Margin tumbled 6809 bps in 2023 and surged 7188 bps in 2024, its largest moves.
• Over 5 years, Operating Margin stood at 24.86% in 2022, then tumbled by 41 bps to 14.76% in 2023, then jumped by 86 bps to 27.5% in 2024, then soared by 68 bps to 46.27% in 2025, then tumbled by 108 bps to 3.52% in 2026.
• The last three Operating Margin figures came in at 3.52% (Q2 2026), 20.85% (Q1 2026), and 46.27% (Q4 2025), per Business Quant data.